Publications

07 Mar 2017
First Look

First Look at New Research, March 7

Making Dental Care Accessible to All in Brazil No abstract available. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/316149-PDF-ENG Harvard Business School Case 817-062 HBS in 2016 The case explores opportunities and... View Details

Keywords: Sean Silverthorne

17 Jan 2012
First Look

First Look: January 17

reference points or anchors to simplify the complex tasks of valuation and negotiation. Read the paper: http://people.hbs.edu/mbaker/cv/papers/refpt.pdf The Four Habits of High-Value Health Care... View Details

Keywords: Sean Silverthorne

29 Apr 2014
First Look

First Look: April 29

Harvard Business School Case 413-096 Novartis: Leading a Global Enterprise Novartis, the world's leading health care company, was formed in 1996 out of a merger of two very different, mid-tier... View Details

Keywords: Sean Silverthorne

03 Nov 2009
First Look

First Look: Nov. 3

Field Experiment in Zambia Authors:Nava Ashraf, James Berry, and Jesse M. Shapiro Publication:American Economic Review (forthcoming) Abstract The controversy over whether and how much to charge for health products in the developing world... View Details

Keywords: Martha Lagace

November 2024
Background Note

Social Enterprise in the MENA Region

By: Brian Trelstad and Ahmed Dahawy

This research note provides an overview of the socio-economic landscape of social enterprise in the Middle East and North Africa. It highlights the diversity of players in the region including social enterprise organizations (in their many forms) and supporting... View Details

2024
Article

Beyond the 510(k): The Regulation of Novel Moderate-Risk Medical Devices, Intellectual Property Considerations, and Innovation Incentives in the FDA’s De Novo Pathway

By: Mateo Aboy, Cristina Crespo and Ariel Stern

Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents an analysis of the interaction between... View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Care and Treatment; Technology Adoption; Technological Innovation; Safety; Medical Devices and Supplies Industry; United States

Read Now

February 2019 (Revised August 2019)
Case

Maccabitech: The Promise of Israel's Healthcare Data

By: Scott Duke Kominers and Carin-Isabel Knoop

Dr. Varda Shalev bridges technology and medicine through Maccabitech, a "research and innovation wing" of Israel's Maccabi Healthcare Services (MHS) that partners with research institutions, pharmaceutical companies, and startups. Shalev hopes to scale Maccabitech's... View Details

Keywords: Big Data; Healthcare; Analytics and Data Science; Digital Platforms; Health Care and Treatment; Innovation and Invention; Research; Entrepreneurship; Risk Management; Israel

February 2011 (Revised June 2011)
Case

Hardina Smythe and the Healthcare Investment Conundrum

By: Matthew Rhodes-Kropf, Ann Leamon and Lisa Strope

Hardina Smythe, a recent MBA graduate, has just joined a top-tier venture capital firm in the difficult environment of late 2010. Her first assignment is to evaluate three different deals and make recommendations to the partners. Each potential investment has strengths... View Details

Keywords: Venture Capital; Asset Management; Private Equity; Entrepreneurship; Investment; Health Care and Treatment; Innovation and Invention; Financial Services Industry

26 Jul 2024
Research & Ideas

Why Great Ideas Get Stuck in Universities

commercialization gap left by companies, “universities will have to be very careful that they don’t shift too far into doing the commercial work,” Roche says. “Because what academia has afforded for so many decades is the freedom to do... View Details

Keywords: by Ben Rand; Health; Health

24 Jun 2014
First Look

First Look: June 24

trust, employee commitment, and "ownership" behaviors of both employees and clients-could explain and be used to predict up to half of the difference in operating income between agency offices of a global service provider. The paper calls for View Details

Keywords: Sean Silverthorne

17 Oct 2012
Research & Ideas

America Needs a Manufacturing Renaissance

community resource because it nourished the livestock that provided a foundation for the local agricultural economy. If the commons fell into disrepair—either through overuse or neglect—everyone suffered. Although taking care of the... View Details

Keywords: by Gary P. Pisano & Willy C. Shih; Manufacturing

21 Feb 2012
First Look

First Look: Feb. 21

Council (SEAC) in 2008. With substantial input from the SEAC, the company set two ambitious sets of ten-year goals: 1996-2005 and 2006-2015 and was largely successful in meeting them or on the way to doing so. In 2011, Neil Hawkins, vice president of sustainability and... View Details

Keywords: Sean Silverthorne

30 Sep 2002
Research & Ideas

Use the Psychology of Pricing To Keep Customers Returning

same concept can be applied to health care. In its current form, most of us pay for blanket health care coverage that entitles us to a number of periodic services such as... View Details

Keywords: by Manda Mahoney

13 Nov 2007
Research & Ideas

Six Steps for Reinvigorating America

to act as "citizen diplomats," spreading greater understanding of our values and helping countries that empower their people and build their economies. Develops an ethos of a community that cares about others and a program of... View Details

Keywords: by Sean Silverthorne

2014
Working Paper

Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms

By: Prithwiraj Choudhury and Tarun Khanna

Since the 1990s, several Western firms have filed patents based on medicinal herbs from emerging markets, evoking protests from local stakeholders against 'bio-piracy'. We explore conditions under which firms and local stakeholders share rents from such patents. Our... View Details

Keywords: Rents From New Technology; Local Stakeholders; Herbal Patents; QCA; Fuzzy Set Analysis; Qualitative Case Studies; Plant-Based Agribusiness; Patents; Emerging Markets; Health Care and Treatment; Business and Stakeholder Relations; Cross-Cultural and Cross-Border Issues; Agriculture and Agribusiness Industry; Pharmaceutical Industry

Read Now

August 2009 (Revised April 2012)
Case

Genzyme's CSR Dilemma: How to Play its HAND

By: Christopher A. Bartlett, Tarun Khanna and Prithwiraj Choudhury

Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases (e.g., malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should... View Details

Keywords: Global Strategy; Health Care and Treatment; Intellectual Property; Corporate Social Responsibility and Impact; Partners and Partnerships; Research and Development; Biotechnology Industry